Product Images Aripiprazole

This appears to be a product label for Aripiprazole tablets made by Exelan Pharmaceuticals. The tablets come in a package with 10mg dosage strength and contain 0.5mg of the active ingredient. The label includes storage instructions and the manufacturer's address.*

This is a description for a medication called Aripiprazole, which is available in tablet form and manufactured by Exelan. The tablets come in different dosages ranging from 5mg to 15mg, and the recommended dosage can be found on the packaging. The medication should be stored in a cool, dry place, and the container should be kept closed. The manufacturer is Erlon Pharmaceuticals located in Nanso, Sweden, and the distributor is Ascont Pharmaceuticals located in Conalip, France.*

This is a label for a medication called Aripiprazole, which comes in tablet form. The manufacturer is EXELAN and it contains 30 tablets per bottle. The dosage and usage directions are not available.*

This is a description of a medication called Aripiprazole. The medication comes in the form of tablets with a dosage strength of 5mg. It is manufactured by Exlan Pharmaceuticals and comes in a package of 30 tablets. The recommended storage temperature for the medication is not available.*

This is a table showing the effect of different drugs on the metabolism of aripiprazole, a medication used to treat various mental disorders. The drugs are classified based on their ability to either inhibit or induce certain enzymes in the liver that are responsible for breaking down aripiprazole. The fold change and 90% confidence intervals of aripiprazole levels in the blood are also provided. The drugs tested include ketoconazole, quinidine, carbamazepine, famotidine, valproate, lithium, and lorazepam.*

This is a table showing the effect of various drugs on aripiprazole, with information on whether they are CYP3A4 inhibitors or inducers, CYP2D6 inhibitors, gastric acid blockers, or other drugs. The table also shows a fold change and a 90% confidence interval for dehydro-aripiprazole relative to a reference without interacting drugs, with values ranging from 0 to 30.*

This appears to be a table summarizing the effects of various factors (such as PK, gender, age, and hepatic/renal impairment) on the pharmacokinetics of a drug called Avripiprazole. The table includes information on changes in AUC and maximum concentration (max) for different groups of patients compared to a reference group. However, without additional context or data, it's difficult to determine the specific implications of these findings.*

This appears to be a table that includes information about different factors such as PK, CYP2D6, Gender, Age, Hepatic Impairment, and Renal Impairment, and their effect on AUC and maximum Vel. However, there is not enough context and the text is not complete, making it difficult to generate a useful description.*